Bruno M. Simoes
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer.
Journal: Cell communication and signaling : CCS
Published: January 02, 2025
Anti-progestin therapy targets hallmarks of breast cancer risk.
Journal: Nature
Published: May 29, 2024
Editorial: Adipokines and hormone-dependent cancers.
Journal: Frontiers in endocrinology
Published: November 17, 2023
Editorial: Sex steroid hormones: effects on breast cancer risk and etiology.
Journal: Frontiers in endocrinology
Published: April 02, 2023
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women.
Journal: Genome medicine
Published: March 11, 2021
Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors.
Journal: Nature communications
Published: November 12, 2020
Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer.
Journal: Oncogene
Published: February 21, 2020
The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling.
Journal: Molecular cancer research : MCR
Published: May 12, 2019
Microenvironmental IL1β promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling.
Journal: Nature communications
Published: February 26, 2019
Last Updated: 09/26/2026